drugset
Drugs / autologous EBV specific CTLs
last change Jun 2012 re-read 3 minutes ago

autologous EBV specific CTLs

Cell therapy

Developed for
head and neck cancer
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Trials 1

today NCT00609219 · Ph 1
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00609219 Aug 2001 → Oct 2007 head and neck cancer Baylor College of Medicine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as autologous EBV specific CTLs ClinicalTrials.gov intervention name — accepted as the source's own label NCT00609219 ↗
Action Deplete “This stimulation will train the T cells to kill cells with EBV on their surface.” NCT00609219 ↗
Modality Cell therapy “cellular immunotherapy targeted against tumor-associated viral antigens” PMID 15542583 ↗ Nov 2004